Position in RCUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$92,730,412
+$11,129,976 QoQ
Shares Held
3,007,798
-20.4% QoQ
Ownership
2.36%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#10
of 228 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. RCUS ranks #7 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,002,863 | $375,096,182 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $173,349,326 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
4,000,567 | $125,057,724 | |
| 4 | BHVN |
Biohaven Ltd.
|
7,660,280 | $113,984,966 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
2,603,162 | $100,742,369 | |
| 6 | CYTK |
Cytokinetics Inc
|
1,100,708 | $93,769,314 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
This page
|
3,007,798 | $92,730,412 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
2,500,673 | $88,498,817 |
All Filings in RCUS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $92,730,412 | 3,007,798 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $81,600,436 | 3,777,798 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $89,834,048 | 3,769,788 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $51,267,702 | 3,769,684 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $32,560,236 | 4,000,029 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $40,249,336 | 5,127,304 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $52,471,421 | 3,523,937 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $53,185,347 | 3,478,440 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $64,654,715 | 4,245,221 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $54,443,444 | 2,883,657 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $19,812,086 | 1,037,282 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $18,619,211 | 1,037,282 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,036,880 | 248,000 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $24,839,782 | 1,201,150 | Shares | Sole | 2023-02-14 | |
| 2022-03-31 | $8,250,383 | 261,419 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $69,059,019 | 1,706,425 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $59,248,070 | 1,699,113 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $45,681,577 | 1,663,568 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $34,755,458 | 1,237,730 | Shares | Sole | 2021-05-17 | |
| 2020-03-31 | $1,367,402 | 98,516 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||